Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Pharmacol Biochem Behav

Retrieve available abstracts of 46 articles:
HTML format

Single Articles

    February 2022
  1. D'SOUZA MS, Seeley SL, Emerson N, Rose-Malkamaki MJ, et al
    Attenuation of nicotine-induced rewarding and antidepressant-like effects in male and female mice lacking regulator of G-protein signaling 2.
    Pharmacol Biochem Behav. 2022;213:173338.
    PubMed     Abstract available

  2. CHEN YM, Lin CH, Lane HY
    Distinctively lower DISC1 mRNA levels in patients with schizophrenia, especially in those with higher positive, negative, and depressive symptoms.
    Pharmacol Biochem Behav. 2022;213:173335.
    PubMed     Abstract available

    January 2022
  3. DONG C, Tian Z, Fujita Y, Fujita A, et al
    Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
    Pharmacol Biochem Behav. 2022;212:173316.
    PubMed     Abstract available

    December 2021
  4. FUREIX C, Trevarthen AC, Finnegan EM, Buckova K, et al
    Do greater levels of in-cage waking inactivity in laboratory mice reflect a spontaneous depression-like symptom? A pharmacological investigation.
    Pharmacol Biochem Behav. 2021;212:173311.
    PubMed     Abstract available

  5. LEUSSIS MP, Thanos JM, Powers A, Peterson E, et al
    Sex differences in long-term behavioral alterations, especially anxiety, following prenatal fluoxetine exposure in C57BL/6 mice.
    Pharmacol Biochem Behav. 2021;211:173293.
    PubMed     Abstract available

  6. HARA H, Suzuki A, Kunugi A, Tajima Y, et al
    TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Pharmacol Biochem Behav. 2021;211:173289.
    PubMed     Abstract available

  7. SUN L, Wang G, Wu Z, Xie Y, et al
    Swimming exercise reduces the vulnerability to stress and contributes to the AKT/GSK3beta/CRMP2 pathway and microtubule dynamics mediated protective effects on neuroplasticity in male C57BL/6 mice.
    Pharmacol Biochem Behav. 2021;211:173285.
    PubMed     Abstract available

    September 2021
  8. FENG C, Ren Y, Zhou J, Dong Y, et al
    Cross-fostering alleviates depression-like behavior mediated by EAAT2 and SNARE complex in prenatal stress offspring rat.
    Pharmacol Biochem Behav. 2021 Sep 3:173269. doi: 10.1016/j.pbb.2021.173269.
    PubMed     Abstract available

  9. ZHANG F, Hillhouse TM, Anderson PM, Koppenhaver PO, et al
    Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice.
    Pharmacol Biochem Behav. 2021;208:173228.
    PubMed     Abstract available

    July 2021
  10. WANG Y, Jiang R, Wu Z, Zhou L, et al
    Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression.
    Pharmacol Biochem Behav. 2021;207:173226.
    PubMed     Abstract available

    June 2021
  11. ZOLFAGHARI FS, Pirri F, Gauvin E, Peeri M, et al
    Exercise and fluoxetine treatment during adolescence protect against early life stress-induced behavioral abnormalities in adult rats.
    Pharmacol Biochem Behav. 2021;205:173190.
    PubMed     Abstract available

    May 2021
  12. REDDY BR, Babu NS, Das T, Bhattacharya D, et al
    Proteome profile of telencephalon associates attenuated neurogenesis with chronic stress induced mood disorder phenotypes in zebrafish model.
    Pharmacol Biochem Behav. 2021;204:173170.
    PubMed     Abstract available

    April 2021
  13. HORMAN T, Ayoub S, Leri F
    Evidence of hypoglycemic anhedonia and modulation by bupropion in rats.
    Pharmacol Biochem Behav. 2021;203:173120.
    PubMed     Abstract available

    March 2021
  14. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats.
    Pharmacol Biochem Behav. 2021 Mar 3:173156. doi: 10.1016/j.pbb.2021.173156.
    PubMed     Abstract available

  15. GAO TH, Ni RJ, Liu S, Tian Y, et al
    Chronic lithium exposure attenuates ketamine-induced mania-like behavior and c-Fos expression in the forebrain of mice.
    Pharmacol Biochem Behav. 2021;202:173108.
    PubMed     Abstract available

    February 2021
  16. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Retraction notice to "Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats" [Pharmacol. Biochem. Behav. 194 (2020) 172939].
    Pharmacol Biochem Behav. 2021;203:173130.
    PubMed     Abstract available

    January 2021
  17. TAFSEER S, Gupta R, Ahmad R, Jain S, et al
    Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder.
    Pharmacol Biochem Behav. 2021;200:173073.
    PubMed     Abstract available

    November 2020
  18. LIU R, Wu XM, He X, Wang RZ, et al
    Contribution of DNA methyltransferases to spared nerve injury induced depression partially through epigenetically repressing Bdnf in hippocampus: Reversal by ketamine.
    Pharmacol Biochem Behav. 2020 Nov 24:173079. doi: 10.1016/j.pbb.2020.173079.
    PubMed     Abstract available

  19. NEIS VB, Moretti M, Rosa PB, Dalsenter YO, et al
    The involvement of PI3K/Akt/mTOR/GSK3beta signaling pathways in the antidepressant-like effect of AZD6765.
    Pharmacol Biochem Behav. 2020;198:173020.
    PubMed     Abstract available

    October 2020
  20. CHRISSOBOLIS S, Luu A, Waldschmidt R, Yoakum M, et al
    Targeting the renin angiotensin system for the treatment of anxiety and depression.
    Pharmacol Biochem Behav. 2020 Oct 25:173063. doi: 10.1016/j.pbb.2020.173063.
    PubMed     Abstract available

  21. SAAVEDRA JS, Garrett PI, Honeycutt SC, Peterson AM, et al
    Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice.
    Pharmacol Biochem Behav. 2020;197:173003.
    PubMed     Abstract available

  22. SMAIL MA, Smith BL, Nawreen N, Herman JP, et al
    Differential impact of stress and environmental enrichment on corticolimbic circuits.
    Pharmacol Biochem Behav. 2020;197:172993.
    PubMed     Abstract available

    July 2020
  23. SPARLING JE, Barbeau K, Boileau K, Konkle ATM, et al
    Environmental enrichment and its influence on rodent offspring and maternal behaviours, a scoping style review of indices of depression and anxiety.
    Pharmacol Biochem Behav. 2020 Jul 20:172997. doi: 10.1016/j.pbb.2020.172997.
    PubMed     Abstract available

    June 2020
  24. KOTANSKA M, Mika K, Salaciak K, Wheeler L, et al
    Pitolisant protects mice chronically treated with corticosterone from some behavioral but not metabolic changes in corticosterone-induced depression model.
    Pharmacol Biochem Behav. 2020;196:172974.
    PubMed     Abstract available

    May 2020
  25. WANG XL, Wang DQ, Jiao FC, Ding KM, et al
    Diurnal rhythm disruptions induced by chronic unpredictable stress relate to depression-like behaviors in rats.
    Pharmacol Biochem Behav. 2020;194:172939.
    PubMed     Abstract available

  26. PHAM TH, Defaix C, Nguyen TML, Mendez-David I, et al
    Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine.
    Pharmacol Biochem Behav. 2020;192:172913.
    PubMed     Abstract available

  27. AN Q, Li C, Chen Y, Yang Y, et al
    Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses.
    Pharmacol Biochem Behav. 2020;192:172910.
    PubMed     Abstract available

    March 2020
  28. WEI Y, Chang L, Hashimoto K
    A historical review of antidepressant effects of ketamine and its enantiomers.
    Pharmacol Biochem Behav. 2020;190:172870.
    PubMed     Abstract available

    mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects.
    Pharmacol Biochem Behav. 2020;190:172854.
    PubMed     Abstract available

  30. LAINIOLA M, Linden AM, Aitta-Aho T
    Behavioral responses of mGluR3-KO mice to the lipopolysaccharide-induced innate inflammatory reaction.
    Pharmacol Biochem Behav. 2020;190:172852.
    PubMed     Abstract available

    February 2020
  31. YOKOYAMA R, Higuchi M, Tanabe W, Tsukada S, et al
    (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Pharmacol Biochem Behav. 2020 Feb 20:172876. doi: 10.1016/j.pbb.2020.172876.
    PubMed     Abstract available

    January 2020
  32. GILBERT JR, Zarate CA Jr
    Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation.
    Pharmacol Biochem Behav. 2020 Jan 17:172856. doi: 10.1016/j.pbb.2020.172856.
    PubMed     Abstract available

  33. DEYAMA S, Duman RS
    Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
    Pharmacol Biochem Behav. 2020;188:172837.
    PubMed     Abstract available

  34. POLESZAK E, Wosko S, Slawinska K, Wyska E, et al
    Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice.
    Pharmacol Biochem Behav. 2020;188:172833.
    PubMed     Abstract available

  35. KATO T, Duman RS
    Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
    Pharmacol Biochem Behav. 2020;188:172827.
    PubMed     Abstract available

    December 2019
  36. WROBEL A, Serefko A, Wozniak A, Kociszewski J, et al
    Duloxetine reverses the symptoms of overactive bladder co-existing with depression via the central pathways.
    Pharmacol Biochem Behav. 2019 Dec 31:172842. doi: 10.1016/j.pbb.2019.172842.
    PubMed     Abstract available

  37. BAVARESCO DV, Uggioni MLR, Ferraz SD, Marques RMM, et al
    Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis.
    Pharmacol Biochem Behav. 2019;188:172838.
    PubMed     Abstract available

    September 2019
  38. LI Q, Wu HR, Fan SJ, Liu DX, et al
    The effects of sub-anesthetic ketamine plus ethanol on behaviors and apoptosis in the prefrontal cortex and hippocampus of adolescent rats.
    Pharmacol Biochem Behav. 2019;184:172742.
    PubMed     Abstract available

  39. XUE SS, Xue F, Ma QR, Wang SQ, et al
    Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling.
    Pharmacol Biochem Behav. 2019;184:172738.
    PubMed     Abstract available

    August 2019
  40. BAMPI SR, Casaril AM, Sabedra Sousa FS, Pesarico AP, et al
    Repeated administration of a selenium-containing indolyl compound attenuates behavioural alterations by streptozotocin through modulation of oxidative stress in mice.
    Pharmacol Biochem Behav. 2019;183:46-55.
    PubMed     Abstract available

  41. SUZUKI A, Murakami K, Tajima Y, Hara H, et al
    TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
    Pharmacol Biochem Behav. 2019;183:80-86.
    PubMed     Abstract available

  42. MAKINO M, Takahashi-Ito K, Murasawa H, Pawlak A, et al
    Memantine ameliorates learning and memory disturbance and the behavioral and psychological symptoms of dementia in thiamine-deficient mice.
    Pharmacol Biochem Behav. 2019;183:6-13.
    PubMed     Abstract available

    June 2019
  43. CHANG L, Zhang K, Pu Y, Qu Y, et al
    Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
    Pharmacol Biochem Behav. 2019;181:53-59.
    PubMed     Abstract available

    May 2019
  44. NASERZADEH R, Abad N, Ghorbanzadeh B, Dolatshahi M, et al
    Simvastatin exerts antidepressant-like activity in mouse forced swimming test: Role of NO-cGMP-KATP channels pathway and PPAR-gamma receptors.
    Pharmacol Biochem Behav. 2019;180:92-100.
    PubMed     Abstract available

    February 2019
  45. ERICKSON EK, Grantham EK, Warden AS, Harris RA, et al
    Neuroimmune signaling in alcohol use disorder.
    Pharmacol Biochem Behav. 2019;177:34-60.
    PubMed     Abstract available

    January 2019
  46. XIONG Z, Zhang K, Ishima T, Ren Q, et al
    Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Pharmacol Biochem Behav. 2019;176:57-62.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.